$73.32 meals Payment -- Regeneron Pharmaceuticals to Dr. Rebecca Adams
Regeneron Pharmaceuticals provides $73.32 in meals to an Allergy & Immunology specialist.
This page provides a detailed analysis of a $73.32 meals payment from Regeneron Pharmaceuticals to Dr. Rebecca Adams. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $73.32 |
| Payment Type | meals |
| Payment Nature | Food and Beverage |
| Pharmaceutical Company | Regeneron Pharmaceuticals |
| Physician | Dr. Rebecca Adams |
| NPI Number | 1644045461 |
| Physician Specialty | Allergy & Immunology |
| Location | Lowell, MA |
| Date of Payment | 2026-02-05 |
| Related Drug/Device | Dupixent |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Regeneron Pharmaceuticals made a $73.32 meals payment to Rebecca Adams, a Allergy & Immunology specialist in Lowell, MA. The payment was associated with Dupixent. The payment of $73.32 to Dr. Rebecca Adams from Regeneron Pharmaceuticals for meals related to Dupixent is a relatively small amount. This payment occurred on February 5, 2026, indicating a recent interaction. The nature of the payment was 'Food and Beverage', specifically meals, which is a common type of interaction in the pharmaceutical industry.
Patient Guidance: What This Payment Means for You
This information details a meal provided by a pharmaceutical company to a healthcare provider, which is a standard practice for sharing information about medications. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for meals to physicians in Allergy & Immunology are common and typically represent a low financial value compared to other forms of compensation.
Regulatory Context: Sunshine Act Requirements
This payment is reported under the Sunshine Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.
Related Topics
This payment is related to the following healthcare transparency topics:
- cms-open-payments
- pharmaceutical-payments
- physician-compensation
- regeneron-pharmaceuticals
- dupixent
- allergy-immunology
Understanding meals Payments
Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.
Frequently Asked Questions About This Payment
What was this $73.32 payment for?
This was a meals payment of $73.32 from Regeneron Pharmaceuticals to Rebecca Adams, categorized as "Food and Beverage". It was associated with Dupixent. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Rebecca Adams accept pharmaceutical money?
Yes, Rebecca Adams received this $73.32 payment from Regeneron Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Rebecca Adams's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this meals payment?
A meals payment of $73.32 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Allergy & Immunology?
To compare this payment against Allergy & Immunology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Allergy & Immunology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Rebecca Adams's relationship with Regeneron Pharmaceuticals?
The payment amount is below the typical threshold for significant financial influence. This $73.32 meals payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Allergy & Immunology?
The payment was for meals, a common and generally low-value interaction.
What should patients do after learning about this payment?
This information details a meal provided by a pharmaceutical company to a healthcare provider, which is a standard practice for sharing information about medications.
What else should I know about this meals payment?
The specific drug mentioned, Dupixent, is an important product for Regeneron in the allergy space.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.